Condition: Autoimmune Diseases · Inflammation · Rejection; Transplant, Liver · Sponsor: Quell Therapeutics Limited
The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
This description comes directly from the study's public registry record.
Gareth Wright · +4(0)2070969012 · contact@quell-tx.com
Always discuss trial participation with your own doctor first.
| Quell Investigator Site 01 | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04838171